Ian Pike

Business Development Director, Proteomics

Ian joined Proteome Sciences in November 2002 from Cancer Research Technology, the technology transfer and business development company owned by Cancer Research UK. Ian holds a Ph.D. in medical microbiology from the University of Leeds and ran a research group at Wellcome Diagnostics and subsequently Murex Biotech Ltd. for 8 years. In the four years after Murex he worked in academic technology transfer performing many licensing deals and working on the formation of three biotech start-ups. He has served as a non-executive director on the boards of Spirogen and Proacta Therapeutics, two biotechnology start-ups formed by Cancer Research Ventures and is currently a director of SEHTA, the South East Healthcare Technologies Alliance. As Business Development Director at Proteome Sciences, Ian is responsible for the commercial development of its ProteoSHOP™ toolkit offering a combination of high-throughput and high sensitivity proteomics. Ian is also responsible for general licensing activities and management of the company’s extensive intellectual property portfolio.